Inhaled corticosteroids and bronchodilator studies in asthma

E-poster session
Chairs: C. Porsbjerg (Copenhagen, Denmark), I. Satia (Hamilton (ON), Canada)

Late Breaking Abstract - Short-acting ß2-agonist use in asthma in Western societies J. Quint (London, United Kingdom), S. Arnetorp (Gothenburg, Sweden), C. Janson (Uppsala, Sweden), S. Boarino (Milan, Italy), J. Kocks (Groningen, Netherlands), I. Gilbert (Wilmington, DE, United States of America), M. Kupczyk (Lodz, Poland), J. Nuevo (Madrid, Spain), N. Lucia Lugogo (Ann Arbor, MI, United States of America), E. Penz (Saskatoon, Saskatchewan, Canada), S. Quirce (Madrid, Spain), C. Raherison-Semjen (Bordeaux, France), R. Van Der Valk (Cambridge, United Kingdom)
Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review A. Czira (Brentford, United Kingdom), A. Martin (Waltham, United States of America), M. Turner (Waltham, United States of America), W. Meeraus (Brentford, United Kingdom), H. Birch (Brentford, United Kingdom), S. Zhang (Collegeville, United States of America)
CAPTAIN: Effects of age on response to triple therapy in patients with inadequately controlled asthma on ICS/LABA L. Boulet (Québec, QC, Canada), L. Lee (Collegeville, PA, United States of America), H. Kerstjens (Groningen, Netherlands), A. Papi (Ferrara, Italy), A. Zarankaite (Stockley Park West, Uxbridge, Middlesex, United Kingdom), I. Pavord (Oxford, United Kingdom), Z. Bailes (Stockley Park West, Uxbridge, Middlesex, United Kingdom), G. Brusselle (Ghent, Belgium), N. Barnes (Brentford, Middlesex and London, United Kingdom), N. Hanania (Houston, TX, United States of America), S. Pascoe (Collegeville, PA, United States of America), J. Oppenheimer (Newark, NJ, United States of America), E. Pizzichini (Brentford, Middlesex (UK) and Santa Catarina, Brazil), A. Fowler (Stockley Park West, Uxbridge, Middlesex, United Kingdom)
As needed therapies in mild to severe asthma: a systematic review and network meta-analysis P. Rogliani (Roma (RM), Italy), B. Ritondo (Roma (RM), Italy), J. Ora (Roma (RM), Italy), M. Cazzola (Roma (RM), Italy), L. Calzetta (Roma (RM), Italy)
Overuse of short-acting beta-agonists (SABA) and risk factors among patients with asthma H. Worth (Fürth, Germany), C. Criée (Göttingen, Germany), C. Vogelmeier (Marburg , Germany), P. Kardos (Frankfurt, Germany), E. Becker (Frankfurt, Germany), K. Kostev (Frankfurt, Germany), I. Mokros (Wedel, Germany), A. Schneider (Wedel, Germany)
Lower ICS dose effect on symptoms and rescue medication use of  indacaterol/glycopyrronium/mometasone (IND/GLY/MF) medium-dose vs salmeterol/fluticasone (Sal/Flu) high-dose plus tiotropium (Tio): ARGON study C. Gessner (Leipzig, Germany), O. Kornmann (Frankfurt, Germany), J. Maspero (Buenos Aires, Argentina), R. Zyl-Smit (Cape Town, South Africa), M. Krüll (Berlin, Germany), A. Sojo (Cáceres, Spain), A. Salina (Basel, Switzerland), P. Gupta (Hyderabad, India), L. Conde (Basel, Switzerland)
Adherence to FDC Budesonide/Formoterol treatment and lung function of Greek asthmatic patients–COMPLETE study N. Rovina (Attica, Greece), D. Simantiraki (Attica, Greece), N. Grekas (Attica, Greece), P. Papanastasiou (Attica, Greece), A. Athanassiou (Attica, Greece), A. Ginis (Attica, Greece)
Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma I. Vähätalo (Seinäjoki and Tampere, Finland), H. Kankaanranta (Seinäjoki and Tampere, Finland), L. Tuomisto (Seinäjoki, Finland), O. Niemelä (Seinäjoki and Tampere, Finland), L. Lehtimäki (Tampere, Finland), P. Ilmarinen (Seinäjoki, Finland)
Effect of triple therapy with extra-fine BDP/FF/GB pMDI during seasonal peaks of asthma exacerbations. A post-hoc analysis of the TRIMARAN and TRIGGER studies A. Papi (Ferrara, Italy), D. Singh (Manchester, United Kingdom), C. Virchow (Rostock, Germany), M. Kots (Parma, Italy), A. Vele (Parma, Italy), G. Georges (Parma, Italy), G. Canonica (Milan, Italy)
Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database. M. Kupczyk (Lodz, Poland), W. Barg (Wroclaw, Poland), G. Bochenek (Kraków, Poland), G. Brozek (Katowice, Poland), D. Brzostek (Warsaw, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Dobek (Warsaw, Poland), R. Gawlik (Katowice, Poland), A. Kucharczyk (Warsaw, Poland), I. Kuprys-Lipinska (Lodz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), E. Zagrajek (Warsaw, Poland), M. Kowalski (Lodz, Poland)
Adherence to 6-month FDC Budesonide/Formoterol treatment and Quality of Life in Greek asthmatic patients-COMPLETE study N. Rovina (Attica, Greece), D. Simantiraki (Attica, Greece), N. Grekas (Attica, Greece), A. Papataxiarchou (Attica, Greece), A. Athanassiou (Attica, Greece), A. Ginis (Attica, Greece)
Prescription behaviour of short-acting ß2-agonists in Switzerland C. Schuoler (Baar, Switzerland), C. Steurer-Stey (Zurich, Switzerland), E. Ullmer (Bern, Switzerland), R. Providoli (Sierre, Switzerland), V. Chicherov (Rotkreuz, Switzerland), M. Korobeynikova (Rotkreuz, Switzerland), S. Wetzel (Rotkreuz, Switzerland), G. Pendl (Baar, Switzerland)
The effect of inhaled corticosteroids on airway hyperresponsiveness to mannitol in patients with Type 2 low asthma M. Hvidtfeldt (Copenhagen, Denmark), A. Pulga (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), M. Hostrup (Copenhagen, Denmark), C. Sanden (Lund, Sweden), O. Nielsen (Aarhus, Denmark), D. Bornesund (Lund, Sweden), C. Clausson (Lund, Sweden), J. Erjefält (Lund, Sweden), C. Porsbjerg (Copenhagen, Denmark)
Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland M. Todorovic (Vienna, Austria), B. Reichard (Eisenstadt, Austria), M. Wolzt (Vienna, Austria), G. Duftschmid (Vienna, Austria), D. Doberer (Vienna, Austria)
Efficacy and safety of as-needed corticosteroid plus fast or short-acting beta-agonists monotherapy in patients with mild asthma: a meta-analysis of randomised controlled trials. C. Barbon (MANILA, Philippines), L. Fernandez (MANILA, Philippines)
(in)Appropriate LAMA Prescribing in Asthma patients: a Cohort Analysis (the ALPACA study) E. Baan (Rotterdam, Netherlands), C. Hoeve (Rotterdam, Netherlands), M. De Ridder (Rotterdam, Netherlands), L. Demoen (Ghent, Belgium), L. Lahousse (Ghent, Belgium), K. Verhamme (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium)
Adhesion to inhaled treatment in patients with asthma and COPD J. Hernandez Borge (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), M. Gómez Vizcaino (Badajoz, Spain), S. Hernández Gómez (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain), M. Antona Rodriguez (Badajoz, Spain)